Finally, recent studies in patients with congenital dyserythropoietic anemia type II (CDAII) uncovered mutations in the SEC23B gene revealing its essential role in erythrocyte lineage development. This evidence concerns the gene SEC23B and Congenital dyserythropoietic anemia type II.